(1)
Tomić, M. The Preoperative Management of Dabigatran and Its Specific Antidote Idarucizumab in Patients With Nonvalvular Atrial Fibrillation – Case Reports. arhfarm 2020, 70 (Notebook 5), 310-318. https://doi.org/10.5937/arhfarm70-28176.